Squarepoint’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Sell
28,986
-39,331
-58% -$156K ﹤0.01% 4064
2025
Q4
$240K Sell
68,317
-370,062
-84% -$1.27M ﹤0.01% 3763
2025
Q3
$1.43M Buy
438,379
+246,361
+128% +$776K ﹤0.01% 2381
2025
Q2
$470K Buy
192,018
+138,542
+259% +$702K ﹤0.01% 3328
2025
Q1
$357K Buy
+53,476
New +$528K ﹤0.01% 3601
2024
Q4
Sell
-53,039
Closed -$980K 5498
2024
Q3
$980K Buy
+53,039
New +$1.09M ﹤0.01% 2623
2024
Q2
Sell
-27,229
Closed -$734K 4610
2024
Q1
$734K Buy
27,229
+769
+3% +$21.8K ﹤0.01% 2802
2023
Q4
$793K Sell
26,460
-20,688
-44% -$457K ﹤0.01% 2692
2023
Q3
$966K Buy
47,148
+30,587
+185% +$556K ﹤0.01% 2343
2023
Q2
$329K Buy
+16,561
New +$335K ﹤0.01% 2910
2023
Q1
Sell
-12,201
Closed -$239K 3738
2022
Q4
$239K Sell
12,201
-11,674
-49% -$215K ﹤0.01% 2694
2022
Q3
$381K Buy
+23,875
New +$373K ﹤0.01% 2344
2022
Q2
Sell
-28,056
Closed -$445K 3319
2022
Q1
$445K Sell
28,056
-13,715
-33% -$237K ﹤0.01% 2075
2021
Q4
$912K Buy
+41,771
New +$1.14M ﹤0.01% 1754
2021
Q2
Sell
-18,923
Closed -$840K 3622
2021
Q1
$840K Sell
18,923
-2,087
-10% -$115K 0.01% 1648
2020
Q4
$1.15M Sell
21,010
-11,878
-36% -$433K 0.01% 1233
2020
Q3
$752K Sell
32,888
-24,827
-43% -$612K 0.01% 1155
2020
Q2
$1.21M Buy
+57,715
New +$1.04M 0.02% 843
2020
Q1
Sell
-19,262
Closed -$438K 2394
2019
Q4
$438K Sell
19,262
-15,316
-44% -$256K ﹤0.01% 1844
2019
Q3
$403K Sell
34,578
-4,286
-11% -$53.2K ﹤0.01% 1733
2019
Q2
$583K Buy
38,864
+5,008
+15% +$87.4K 0.01% 1572
2019
Q1
$594K Sell
33,856
-13,563
-29% -$214K 0.01% 1394
2018
Q4
$703K Buy
47,419
+36,219
+323% +$601K 0.01% 1070
2018
Q3
$276K Buy
+11,200
New +$243K ﹤0.01% 1581
2017
Q4
Sell
-31,741
Closed -$226K 2302
2017
Q3
$226K Buy
31,741
+28,022
+753% +$128K ﹤0.01% 1328
2017
Q2
$28K Buy
+3,719
New +$27.7K ﹤0.01% 1480
2017
Q1
Sell
-3,795
Closed -$93K 1850
2016
Q4
$93K Buy
+3,795
New +$108K ﹤0.01% 1632

Other funds holding RCKT